GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » Debt-to-Revenue

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is PD-RX Pharmaceuticals Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PD-RX Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. PD-RX Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. PD-RX Pharmaceuticals's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.


PD-RX Pharmaceuticals Debt-to-Revenue Historical Data

The historical data trend for PD-RX Pharmaceuticals's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PD-RX Pharmaceuticals Debt-to-Revenue Chart

PD-RX Pharmaceuticals Annual Data
Trend
Debt-to-Revenue

PD-RX Pharmaceuticals Quarterly Data
Debt-to-Revenue

Competitive Comparison of PD-RX Pharmaceuticals's Debt-to-Revenue

For the Medical Distribution subindustry, PD-RX Pharmaceuticals's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PD-RX Pharmaceuticals's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PD-RX Pharmaceuticals's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PD-RX Pharmaceuticals's Debt-to-Revenue falls into.



PD-RX Pharmaceuticals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PD-RX Pharmaceuticals's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

PD-RX Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.


PD-RX Pharmaceuticals Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PD-RX Pharmaceuticals's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Headlines

From GuruFocus

PD-Rx Declares Dividend

By PRNewswire PRNewswire 12-06-2018

PD-Rx Declares Dividend

By PRNewswire PRNewswire 05-07-2018